Ribociclib-induced Vitiligo: a Case Report

Dermatol Pract Concept. 2022 Apr 1;12(2):e2022045. doi: 10.5826/dpc.1202a45. eCollection 2022 May.
No abstract available

Keywords: adverse event; breast cancer; ribociclib; selective cyclin-dependent kinase 4/6 inhibitors; vitiligo.